Drug therapy for celiac sprue

Details Drug therapy for celiac sprue Drug therapy for celiac sprue

A - Human Necessities

61

K

A61K 38/00 (2006.01) A61K 31/42 (2006.01) A61K 38/48 (2006.01) C07D 261/04 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2487247

Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.

L'invention concerne l'administration d'une dose efficace d'un inhibiteur de la tTGase à un patient souffrant d'une maladie coeliaque ou de dermatite herpétiforme. Une telle administration permet de réduire les effets toxiques d'oligopeptides du gluten toxique, atténuant ou éliminant ainsi les effets néfastes du gluten.

Affiliated with

Also associated with

Rating

Drug therapy for celiac sprue does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug therapy for celiac sprue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug therapy for celiac sprue will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2033841